SPTX Stock Chart & Stats
$21.58
$1.07(5.22%)
―
--
Day’s Range― - ―
52-Week Range$14.85 - $23.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)882.88K
Market Cap
$1.16B
Enterprise Value$0.00
Total Cash (Recent Filing)$182.60M
Total Debt (Recent Filing)$5.34M
Price to Earnings (P/E)―
Beta-2.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding53,530,550
10 Day Avg. Volume501,401
30 Day Avg. Volume882,884
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-8.29
Price to Sales (P/S)0.00
P/FCF Ratio-9.79
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$35.50Price Target Upside― Downside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SPTX FAQ
What was Seaport Therapeutics, Inc.’s price range in the past 12 months?
Seaport Therapeutics, Inc. lowest stock price was $14.85 and its highest was $23.00 in the past 12 months.
What is Seaport Therapeutics, Inc.’s market cap?
Seaport Therapeutics, Inc.’s market cap is $1.16B.
When is Seaport Therapeutics, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Seaport Therapeutics, Inc.’s earnings last quarter?
Currently, no data Available
Is Seaport Therapeutics, Inc. overvalued?
According to Wall Street analysts Seaport Therapeutics, Inc.’s price is currently Undervalued.
Does Seaport Therapeutics, Inc. pay dividends?
Seaport Therapeutics, Inc. does not currently pay dividends.
What is Seaport Therapeutics, Inc.’s EPS estimate?
Seaport Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Seaport Therapeutics, Inc. have?
Seaport Therapeutics, Inc. has 53,530,550 shares outstanding.
What happened to Seaport Therapeutics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Seaport Therapeutics, Inc.?
Currently, no hedge funds are holding shares in SPTX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Seaport Therapeutics, Inc. Stock Smart Score
Company Description
Seaport Therapeutics, Inc.
Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions. The company is primarily engaged in tackling disorders like depression and anxiety, utilizing its unique Glyph technology. This exclusive platform is engineered to allow for oral administration of drugs, circumventing initial metabolic processing in the liver, and thereby reducing the risk of liver enzyme elevations, hepatotoxicity, and other potential adverse reactions. Every therapeutic agent in their pipeline incorporates this advanced platform, with all research and development efforts exclusively dedicated to neuropsychiatric applications. Founded in 2024 and situated in Boston, Massachusetts, the company connects with medical professionals and influential experts across the healthcare and neuropsychiatric sectors.
SPTX Stock 12 Month Forecast
Average Price Target
$35.50
Ownership Overview
Options Prices
Currently, No data available
---